MagantaTM Plus

Magaldrate+Simethicone
Non-systemic Antacid & Antiflatulent (Antiulcerant)

Indication:

Hyperacidity, gastric and duodenal ulcer, gastritis, heartburn, dyspepsia, gastroesophageal reflux. It is also indicated for the relief of flatulence, abdominal distention and windy colic.

Dosage & Administration:

Maganta ^TM Plus Tablet: 1-4 chewable tablets, 20 to 60 minutes after meals and at bedtime, or as directed by the physician.
Maganta ^TM Plus Suspension: 2-4 teaspoonfuls (10-20 ml) of suspension, 20 to 60 minutes after meals and at bedtime, or as directed by the physician.

Preparation:

Maganta ^TM Plus Tablet: Each box contains 100 chewable tablets.
Maganta ^TM Plus Suspension: Each PET bottle contains 200 ml suspension.